| Date Filed | Type | Description |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/10/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/06/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 10/05/2023 |
4
| Bozic Carmen (EVP and CMO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 5,651 shares
@ $345.28, valued at
$2M
|
|
| 10/05/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 10/03/2023 |
4
| Biller Jonathan (EVP and Chief Legal Officer) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Paid exercise price by delivering 408 shares
@ $350.72, valued at
$143.1k
Sold 610 shares
@ $346.76, valued at
$211.5k
|
|
| 10/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 10/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/25/2023 |
4
| Tatsis Ourania (EVP, Chief Reg. & Quality Off.) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 2,500 shares
@ $355, valued at
$887.5k
|
|
| 08/23/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/14/2023 |
4
| Kearney Terrence C (Director) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 10,000 shares
@ $350, valued at
$3.5M
Exercised 10,000 options to buy
@ $127.54, valued at
$1.3M
|
|
| 08/14/2023 |
4
| Tatsis Ourania (EVP, Chief Reg. & Quality Off.) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 5,750 shares
@ $345.79, valued at
$2M
|
|
| 08/14/2023 |
4
| Sachdev Amit (EVP, Chief Patient Officer) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 10,031 shares
@ $350, valued at
$3.5M
|
|
| 08/11/2023 |
4
| ALTSHULER DAVID (EVP, Global Research and CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 63 shares
@ $345.51, valued at
$21.8k
|
|
| 08/11/2023 |
4
| Bhatia Sangeeta N. (Director) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 242 shares
@ $345.51, valued at
$83.6k
|
|
| 08/10/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/10/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/10/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/09/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/09/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/02/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/01/2023 |
8-K
| Quarterly results |
| 07/18/2023 |
4
| SACHS BRUCE I (Director) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 1,697 shares
@ $355.54, valued at
$603.4k
Sold 5,711 shares
@ $356.75, valued at
$2M
Sold 3,842 shares
@ $357.29, valued at
$1.4M
Granted 125 restricted stock units
@ $350.79, valued at
$43.8k
Exercised 11,250 options to buy
@ $127.54, valued at
$1.4M
|
|
| 07/18/2023 |
4
| MCKENZIE DIANA (Director) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Granted 90 restricted stock units
@ $350.79, valued at
$31.5k
|
|
| 07/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/01/2023 |
4
| Arbuckle Stuart A (EVP, COO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 82 shares
@ $329.82, valued at
$27k
|
|
| 06/01/2023 |
4
| Ambrose Kristen (SVP & Chief Accounting Officer) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 289 shares
@ $329.82, valued at
$95.3k
|
|
| 05/18/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 05/09/2023 |
4
| Sanna Bastiano (EVP, Cell & Genetic Therapies) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 422 shares
@ $350.03, valued at
$147.7k
Sold 2,850 shares
@ $350, valued at
$997.5k
|
|
| 05/09/2023 |
4
| LEIDEN JEFFREY M (Executive Chairman) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 708 shares
@ $349.38, valued at
$247.4k
Sold 171 shares
@ $350.3, valued at
$59.9k
Sold 1,125 shares
@ $349, valued at
$392.6k
|
|
| 05/08/2023 |
144
| Form 144 - Report of proposed sale of securities: |
|